Concepedia

David C. Tully

DC

32

Publications

3.5K

Citations

25

H-Index

1997

Active since

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Novartis (Singapore)

Novartis (United States)

Novartis (Switzerland)

Novartis (United Kingdom)

David C. Tully is an author at Genomics Institute of the Novartis Research Foundation specializing in natural sciences, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1997–2020

32

Publications

32

Chemical activation of the mechanotransduction channel Piezo1

Ruhma Syeda, Jie Xu, Adrienne E. Dubin et al. · eLife · 2015 · 706 citations · Full text

Targeting Plasmodium PI(4)K to eliminate malaria

Case W. McNamara, Chek Shik Lim, Siau Hoi Lim et al. · Nature · 2013 · 419 citations · Full text

, , +4

Dendrimers at surfaces and interfaces: chemistry and applications

David C. Tully, Jean M. J. Fréchet · Chemical Communications · 2001 · 264 citations

, , +12

Functional Profiling of Recombinant NS3 Proteases from All Four Serotypes of Dengue Virus Using Tetrapeptide and Octapeptide Substrate Libraries

Jun Li, Siew Pheng Lim, David Beer et al. · Journal of Biological Chemistry · 2005 · 246 citations · Full text

Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)

David C. Tully, Paul V. Rucker, D. CHIANELLI et al. · Journal of Medicinal Chemistry · 2017 · 224 citations · Full text

, , +20

Rows per page

1–5 of 32